Andrea Zanini1, Ernesto Crisafulli2, Michele D'Andria3, Cristina Gregorini3, Francesca Cherubino4, Elisabetta Zampogna4, Andrea Azzola5, Antonio Spanevello6, Nicola Schiavone7, Alfredo Chetta2. 1. Pulmonary Rehabilitation, Clinic of Rehabilitation, Ente Ospedaliero Cantonale, Novaggio, Switzerland. andrea.zanini2@eoc.ch. 2. Respiratory Disease and Lung Function Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy. 3. Division of General Medicine, Ospedale Malcantonese, Castelrotto, Switzerland. 4. Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy. 5. Pulmonology Service, Department of Internal Medicine, Ente Ospedaliero Cantonale, Lugano, Switzerland. 6. Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese-Como, Italy. 7. Pulmonary Rehabilitation, Clinic of Rehabilitation, Ente Ospedaliero Cantonale, Novaggio, Switzerland.
Abstract
BACKGROUND: The sit-to-stand (STS) test is a feasible tool for measuring peripheral muscle strength of the lower limbs. There is evidence of increasing use of STS tests in patients with COPD. We sought to evaluate in subjects with COPD the minimum clinically important difference in 30-s STS test after pulmonary rehabilitation. METHODS: Stable COPD subjects undergoing a 30-s STS test and a 6-min walk test (6MWT) before and after pulmonary rehabilitation were included. Responsiveness to pulmonary rehabilitation was determined by the change in 30-s STS test results (Δ 30-s STS) before and after pulmonary rehabilitation. The minimum clinically important difference was evaluated using an anchor-based method. RESULTS: 96 subjects with moderate-to-severe COPD were included. At baseline, 30-s STS test results were significantly related to distance covered in a 6MWT (6MWD) (r = 0.65, P < .001), FVC (r = 0.46, P < .001), PaCO2 (r = -0.42, P < .001), FEV1 (r = 0.39, P < .001), and age (r = -0.31, P = .002). After pulmonary rehabilitation, a significant improvement in 30-s STS test results was observed (mean difference +2 repetitions, P < .001). The Δ30-s STS was positively related to Δ6MWD (r = 0.62, P < .001), transitional dyspnea index (r = 0.67, P < .001), and baseline residual volume (r = 0.27, P = .007). The receiver operating characteristic curves method identified a Δ 30-s STS cut-off of 2 repetitions as the best discriminating value (area under the curve: 0.892, P < .001) to identify the minimum clinically important difference for Δ6MWD (30 m). In a multivariate logistic regression model, baseline 30-s STS (odds ratio 2.63; 95% CI 1.09-6.35, P = .031) and diffusing capacity of the lung for carbon monoxide (< 53% predicted) (odds ratio 2.49, 95% CI 1.04-5.98, P = .041) predict the risk to have a Δ 30-s STS ≥ 2 repetitions. CONCLUSIONS: Our study indicates that in stable subjects with moderate-to-severe COPD, the 30-s STS test was a sensitive tool to assess the efficacy of pulmonary rehabilitation. A Δ 30-s STS of ≥ 2 repetitions represented the minimum clinically important difference, which may be predicted by the baseline ability in the 30-s STS test and lung function in terms of diffusing lung capacity (ClinicalTrials.gov registration NCT03627624).
BACKGROUND: The sit-to-stand (STS) test is a feasible tool for measuring peripheral muscle strength of the lower limbs. There is evidence of increasing use of STS tests in patients with COPD. We sought to evaluate in subjects with COPD the minimum clinically important difference in 30-s STS test after pulmonary rehabilitation. METHODS: Stable COPD subjects undergoing a 30-s STS test and a 6-min walk test (6MWT) before and after pulmonary rehabilitation were included. Responsiveness to pulmonary rehabilitation was determined by the change in 30-s STS test results (Δ 30-s STS) before and after pulmonary rehabilitation. The minimum clinically important difference was evaluated using an anchor-based method. RESULTS: 96 subjects with moderate-to-severe COPD were included. At baseline, 30-s STS test results were significantly related to distance covered in a 6MWT (6MWD) (r = 0.65, P < .001), FVC (r = 0.46, P < .001), PaCO2 (r = -0.42, P < .001), FEV1 (r = 0.39, P < .001), and age (r = -0.31, P = .002). After pulmonary rehabilitation, a significant improvement in 30-s STS test results was observed (mean difference +2 repetitions, P < .001). The Δ30-s STS was positively related to Δ6MWD (r = 0.62, P < .001), transitional dyspnea index (r = 0.67, P < .001), and baseline residual volume (r = 0.27, P = .007). The receiver operating characteristic curves method identified a Δ 30-s STS cut-off of 2 repetitions as the best discriminating value (area under the curve: 0.892, P < .001) to identify the minimum clinically important difference for Δ6MWD (30 m). In a multivariate logistic regression model, baseline 30-s STS (odds ratio 2.63; 95% CI 1.09-6.35, P = .031) and diffusing capacity of the lung for carbon monoxide (< 53% predicted) (odds ratio 2.49, 95% CI 1.04-5.98, P = .041) predict the risk to have a Δ 30-s STS ≥ 2 repetitions. CONCLUSIONS: Our study indicates that in stable subjects with moderate-to-severe COPD, the 30-s STS test was a sensitive tool to assess the efficacy of pulmonary rehabilitation. A Δ 30-s STS of ≥ 2 repetitions represented the minimum clinically important difference, which may be predicted by the baseline ability in the 30-s STS test and lung function in terms of diffusing lung capacity (ClinicalTrials.gov registration NCT03627624).
Authors: Benjamin Kelly; Aidan Innes; Marc Holl; Laura Mould; Susan Powell; Danielle Burns; Patrick Doherty; Greg Whyte; James King; Davina Deniszczyc Journal: Front Public Health Date: 2021-05-13
Authors: Samantha Harrison; Krzysztof Bierski; Naomi Burn; Sarah Mclusky; Victoria McFaull; Andrew Russell; Gaynor Williams; Siân Williams; Jane Macnaughton Journal: BMJ Open Respir Res Date: 2020-11
Authors: Carolina X Sandler; Misa Matsuyama; Tamara L Jones; John Bashford; Danette Langbecker; Sandra C Hayes Journal: J Neurooncol Date: 2021-04-28 Impact factor: 4.130
Authors: Rakhmat Ari Wibowo; Riskah Nurámalia; Herlin Ajeng Nurrahma; Eva Oktariani; Jajar Setiawan; Ajeng Viska Icanervilia; Denny Agustiningsih Journal: Int J Environ Res Public Health Date: 2022-04-01 Impact factor: 3.390
Authors: Zheng Wang; Jianhua Yan; Shu Meng; Jiajia Li; Yi Yu; Tingting Zhang; Raymond C C Tsang; Doa El-Ansary; Jia Han; Alice Y M Jones Journal: Front Cardiovasc Med Date: 2022-08-25